Anxiolytic drug targets: beyond the usual suspects.
Gordon
Joshua A
JA
Center for Neurobiology and Behavior, Columbia University, New York State Psychiatric Institute, New York, New York 10032, USA. jg343@columbia.edu
D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001008:Anxiety Disorders / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000502:physiology*; D051379:Mice; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000502:physiology*; D051744:Protein Kinase C-epsilon; D011963:Receptors, GABA-A / Q000187:drug effects
D014151:Anti-Anxiety Agents; D007527:Isoenzymes; D011963:Receptors, GABA-A; C497256:Prkce protein, mouse; C497255:PRKCE protein, human; D011493:Protein Kinase C; D051744:Protein Kinase C-epsilon